Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases.
Amaravadi RK, Schuchter LM, McDermott DF, Kramer A, Giles L, Gramlich K, Carberry M, Troxel AB, Letrero R, Nathanson KL, Atkins MB, O'Dwyer PJ, Flaherty KT.
Amaravadi RK, et al.
Clin Cancer Res. 2009 Dec 15;15(24):7711-7718. doi: 10.1158/1078-0432.CCR-09-2074.
Clin Cancer Res. 2009.
PMID: 19996224
Free PMC article.